Loading cancer entity…
Loading cancer entity…
Clinical trials
3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (571)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00403377 | Investigation of a Behavioral Substitute for Sunbathing | completed | Phase 1 / Phase 2 | 307 | University of Massachusetts, WorcesterOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT00432107 | A Study to Assess APO866 for the Treatment of Advanced Melanoma | completed | Phase 2 | 25 | Valerio TherapeuticsINDUSTRY | 4 | Sep 29, 2015 | clinicaltrials |
| The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure |
| completed |
| — |
| 9 |
| New Mexico Cancer Research AllianceOTHER |
| 1 |
| Sep 28, 2015 |
| clinicaltrials |
| NCT01008527 | Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 | completed | Phase 1 | 22 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2015 | clinicaltrials |
| NCT01765569 | A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma | completed | Phase 1 | 29 | Hoffmann-La RocheINDUSTRY | 5 | Sep 23, 2015 | clinicaltrials |
| NCT00818480 | An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155 | completed | Phase 2 | 10 | Astellas Pharma IncINDUSTRY | 1 | Sep 4, 2015 | clinicaltrials |
| NCT01009775 | A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma | completed | Phase 2 | 64 | Astellas Pharma IncINDUSTRY | 2 | Sep 4, 2015 | clinicaltrials |
| NCT00275496 | Multicenter Selective Lymphadenectomy Trial (MSLT) | completed | Phase 3 | 2,001 | Saint John's Cancer InstituteOTHER | 0 | Sep 2, 2015 | clinicaltrials |
| NCT00139360 | Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma | completed | Phase 2 | 35 | Haukeland University HospitalOTHER | 1 | Aug 27, 2015 | clinicaltrials |
| NCT00723710 | Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600) | completed | — | 299 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 26, 2015 | clinicaltrials |
| NCT01107418 | A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma | completed | Phase 1 | 52 | Hoffmann-La RocheINDUSTRY | 2 | Aug 26, 2015 | clinicaltrials |
| NCT00978913 | Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma | completed | Phase 1 | 31 | Inge Marie SvaneOTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT00937625 | T-cell Based Immunotherapy for of Melanoma | completed | Phase 1 / Phase 2 | 31 | Inge Marie SvaneOTHER | 1 | Aug 18, 2015 | clinicaltrials |
| NCT00866177 | MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 2 | 167 | National Cancer Institute (NCI)NIH | 1 | Aug 11, 2015 | clinicaltrials |
| NCT02508909 | Videoscopic Ilioinguinal Lymphadenectomy for Melanoma | completed | N/A | 23 | Istituto Oncologico Veneto IRCCSOTHER | 0 | Jul 27, 2015 | clinicaltrials |
| NCT01480323 | A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 | completed | Phase 2 | 15 | University Hospital TuebingenOTHER | 1 | Jul 21, 2015 | clinicaltrials |
| NCT00518050 | Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns | completed | — | 160 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 16, 2015 | clinicaltrials |
| NCT01672450 | A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma | completed | Phase 1 | 12 | University of UtahOTHER | 1 | Jul 8, 2015 | clinicaltrials |
| NCT02050594 | Ipilimumab 12-month Intensive Pharmacovigilance Protocol | completed | — | 6 | Bristol-Myers SquibbINDUSTRY | 1 | Jul 7, 2015 | clinicaltrials |
| NCT00855452 | Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors(rIL-2(LAK)) | completed | Phase 2 | 20 | Hadassah Medical OrganizationOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT01681212 | Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma | completed | Phase 2 | 21 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 11, 2015 | clinicaltrials |
| NCT00022464 | CCI-779 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | City of Hope Medical CenterOTHER | 2 | Jun 8, 2015 | clinicaltrials |
| NCT00110994 | Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma | completed | Phase 2 | 101 | BayerINDUSTRY | 1 | Jun 8, 2015 | clinicaltrials |
| NCT02076633 | Intratumoral Administration of L19IL2/L19TNF | completed | Phase 2 | 21 | Philogen S.p.A.INDUSTRY | 1 | May 27, 2015 | clinicaltrials |
| NCT01654692 | A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma(NIBIT-M1) | completed | Phase 2 | 86 | Italian Network for Tumor BiotherapyOTHER | 1 | May 13, 2015 | clinicaltrials |
| NCT00053391 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | 62 | University Hospital ErlangenOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00074230 | Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma | completed | Phase 1 / Phase 2 | 82 | University Hospital ErlangenOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00453050 | Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | completed | Phase 1 | 11 | University of OklahomaOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT00885534 | Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma | completed | Phase 2 | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT01433302 | Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass | completed | — | 21 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT01526486 | Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer | completed | N/A | 29 | Emory UniversityOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT01960634 | Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma(BRAFV600) | completed | — | 58 | Grupo Español Multidisciplinar de MelanomaOTHER | 1 | May 5, 2015 | clinicaltrials |
| NCT00020540 | Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00091338 | Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00005057 | Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma | completed | Phase 1 | — | National Human Genome Research Institute (NHGRI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019175 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00826995 | Comparison of Video-Based Versus Written Patient Education on Melanoma | completed | N/A | 78 | University of California, DavisOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT00279058 | The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2 | completed | Phase 1 / Phase 2 | 24 | Hadassah Medical OrganizationOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01770002 | Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? | completed | N/A | 50 | University of California, DavisOTHER | 1 | Apr 16, 2015 | clinicaltrials |
| NCT00089063 | Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00276835 | Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer | completed | Early Phase 1 | 15 | Northwestern UniversityOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00984464 | Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma | completed | Phase 2 | 14 | Oncolytics BiotechINDUSTRY | 1 | Apr 10, 2015 | clinicaltrials |
| NCT01924923 | New Biopsy Technique for Uveal Melanoma | completed | — | 1 | Greater Houston Retina ResearchOTHER | 1 | Mar 26, 2015 | clinicaltrials |
| NCT00006237 | S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma | completed | Phase 3 | 432 | SWOG Cancer Research NetworkNETWORK | 2 | Mar 25, 2015 | clinicaltrials |
| NCT00029900 | ADI-PEG in Patients With Metastatic Melanoma | completed | Phase 1 | 15 | FDA Office of Orphan Products DevelopmentFED | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00668512 | Intratumoral Injection Of Alpha-Gal Glycosphingolipids | completed | Phase 1 | 12 | University of Massachusetts, WorcesterOTHER | 1 | Mar 19, 2015 | clinicaltrials |
| NCT00753415 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | completed | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2015 | clinicaltrials |
| NCT01127594 | Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion | completed | Phase 1 | 29 | Douglas TylerOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01752257 | EF5 in Melanoma Patients | completed | Phase 1 | 15 | Douglas TylerOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT00565968 | Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg | completed | Phase 1 | 20 | Duke UniversityOTHER | 1 | Mar 6, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Oct 1, 2015source: clinicaltrials